Calciphylaxis is more commonly seen in
## **Core Concept**
Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare and serious disorder characterized by the deposition of calcium in the small and medium-sized blood vessels, leading to tissue ischemia and necrosis. It predominantly occurs in patients with chronic kidney disease (CKD), especially those on dialysis. The condition involves complex pathophysiological mechanisms including disturbances in calcium and phosphate metabolism, secondary hyperparathyroidism, and vascular calcification.
## **Why the Correct Answer is Right**
The correct answer, **D. Chronic kidney disease (CKD) patients on dialysis**, is right because calciphylaxis is most commonly observed in patients with end-stage renal disease (ESRD) who are undergoing dialysis. This population is particularly susceptible due to their compromised renal function, which leads to impaired calcium and phosphate homeostasis, and often, secondary hyperparathyroidism. These factors contribute to the development of vascular calcification and calciphylaxis.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while certain autoimmune conditions may share some risk factors with calciphylaxis, such as vascular calcification, they are not the primary or most common association.
- **Option B:** This option is incorrect as there is no well-established direct link between calciphylaxis and liver disease that makes it more common in this population compared to CKD patients on dialysis.
- **Option C:** This option is incorrect because, although diabetes mellitus can contribute to vascular disease and shares some risk factors with calciphylaxis, such as CKD, it is not as directly associated with calciphylaxis as CKD on dialysis.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that calciphylaxis has a high mortality rate and is often associated with severe pain and poor wound healing. Early recognition and management, including optimizing mineral and bone disorder treatment in CKD, are crucial. A classic clinical correlation is that calciphylaxis can be precipitated by calcium-containing phosphate binders, vitamin D analogs, and elevated calcium-phosphate product.
## **Correct Answer:** D. Chronic kidney disease (CKD) patients on dialysis.